• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Twitter And 20 Stocks Moving Premarket

    7/8/22 6:33:30 AM ET
    $ACRX
    $AEZS
    $ALNA
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACRX alert in real time by email

    Gainers

    • Seritage Growth Properties (NYSE:SRG) rose 35.7% to $8.25 in pre-market trading after gaining around 10% on Thursday. Seritage Growth Properties filed its preliminary proxy materials with the U.S. Securities and Exchange Commission.
    • Insignia Systems, Inc. (NASDAQ:ISIG) rose 33.1% to $10.78 in pre-market trading after gaining around 6% on Thursday.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) rose 27.4% to $0.2689 in pre-market trading after gaining around 19% on Thursday. Allena Pharmaceuticals recently announced rescheduling of special meeting to approve reverse stock split.
    • Aprea Therapeutics, Inc. (NASDAQ:APRE) rose 18.9% to $0.9511 in pre-market trading. Wedbush initiated coverage on Aprea Therapeutics with an Outperform rating and announced a price target of $3.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) rose 12.4% to $2.44 in pre-market trading. Clovis Oncology said on July 1, it had a Type A meeting with the FDA.
    • Aqua Metals, Inc. (NASDAQ:AQMS) rose 11.3% to $0.8575 in pre-market trading.
    • Aeterna Zentaris Inc. (NASDAQ:AEZS) rose 9.3% to $0.2278 in pre-market trading. Aeterna Zentaris announced further adjournment of shareholder meeting.
    • MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) rose 8.6% to $3.25 in pre-market trading after gaining 9% on Thursday.
    • MediaCo Holding Inc. (NASDAQ:MDIA) rose 8.1% to $3.07 in pre-market trading after gaining 5% on Thursday.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 6.4% to $1.33 in pre-market trading after declining 6% on Thursday.

    Don’t forget to check out our premarket coverage here .

    Losers

    • Enjoy Technology, Inc. (NASDAQ:ENJY) fell 37.7% to $0.25 in pre-market trading. Enjoy Technology said that the company received a written notice from NASDAQ on delisting.
    • Upstart Holdings, Inc. (NASDAQ:UPST) fell 17.9% to $27.69 in pre-market trading after the company reported preliminary results for the second quarter. The company said it sees Q2 preliminary revenue of $228 million, versus earlier forecast of $295 million to $305 million. Net loss is seen in the range of $31 million to $27 million.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) shares fell 9.2% to $1.08 in pre-market trading. American Rebel shares jumped 56% on Thursday after the company announced it has entered an agreement to acquire Champion Safe Company in a transaction valued at approximately $9.9 million.
    • SCWorx Corp. (NASDAQ:WORX) shares fell 8.6% to $0.72 in pre-market trading. SCWorx recently announced a common stock purchase agreement with an institutional investor for up to $5 million.
    • Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) fell 8% to $0.69 in pre-market trading.
    • Grove Collaborative Holdings, Inc. (NASDAQ:GROV) fell 7.9% to $6.79 in pre-market trading. Grove Collaborative shares jumped 84% on Thursday after the company announced retail expansion into Kohl's, Giant Eagle and Meijer.
    • AcelRx Pharmaceuticals, Inc (NASDAQ:ACRX) fell 6.5% to $0.33 in pre-market trading after jumping 36% on Thursday.
    • Atlassian Corporation Plc (NASDAQ:TEAM) fell 6.4% to $200.00 in pre-market trading.
    • GameStop Corp. (NYSE:GME) shares fell 6% to $126.97 in pre-market trading. GameStop fired its CFO, Mike Recupero and is also reportedly planning company-wide layoffs. The company also announced appointment of Diana Saadeh-Jajeh as CFO, effective immediately.
    • Twitter, Inc. (NYSE:TWTR) fell 4.2% to $37.16 in pre-market trading. Wedbush maintained Twitter with a Neutral and lowered the price target from $54 to $43.
    • Prudential plc (NYSE:PUK) fell 3.7% to $24.00 in pre-market trading after gaining more than 4% on Thursday.
    Get the next $ACRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRX
    $AEZS
    $ALNA
    $APRE

    CompanyDatePrice TargetRatingAnalyst
    Atlassian Corporation
    $TEAM
    2/6/2026$135.00 → $130.00Outperform
    BMO Capital Markets
    Atlassian Corporation
    $TEAM
    2/4/2026$195.00 → $135.00Outperform
    BMO Capital Markets
    Prudential Public Limited Company
    $PUK
    1/7/2026Buy
    Deutsche Bank
    Upstart Holdings Inc.
    $UPST
    1/6/2026$59.00Buy
    Truist
    Atlassian Corporation
    $TEAM
    12/17/2025$220.00Buy
    BTIG Research
    Atlassian Corporation
    $TEAM
    10/31/2025$190.00 → $195.00Outperform
    BMO Capital Markets
    Atlassian Corporation
    $TEAM
    10/24/2025$200.00 → $190.00Outperform
    BMO Capital Markets
    Atlassian Corporation
    $TEAM
    9/23/2025$200.00Neutral
    BofA Securities
    More analyst ratings

    $ACRX
    $AEZS
    $ALNA
    $APRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    American Rebel Holdings, Inc (NASDAQ: AREB) Files Appeal of Nasdaq Delisting Determination, Preserving Listing Pending Hearing

    American Rebel Appeals Nasdaq Delisting After Continued Strategic Stockholder Discussions, Ensuring Continued Trading of Common Shares on Nasdaq Under Symbol AREB Nashville, Tennessee, Feb. 11, 2026 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ:AREB, AREBW)) ("American Rebel" or the "Company") today announced that it has formally filed an appeal with Nasdaq in response to the Nasdaq Staff Delisting Determination dated February 4, 2026. The appeal was submitted ahead of the 4:00 p.m. ET deadline on February 11, 2026. As a result, the Company's Nasdaq listing will be maintained during the appeal process, and trading of the Company's common stock and warrants on The Nasdaq Capita

    2/11/26 3:36:00 PM ET
    $AREB
    Plastic Products
    Industrials

    Aqua Metals Enters Into a Term Sheet to Acquire Leading Energy Storage Company Lion Energy

    Combined Entity Would Integrate Energy Storage Products, Proprietary Energy Management Software, Recycling, and Battery Materials into a Single Platform Lion Energy is a Revenue-Generating Business, Enhanced by Proprietary Software and Positioned to Participate in Expanding Energy & Virtual Power Plant Markets RENO, Nev. and AMERICAN FORK, Utah, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ:AQMS), a pioneer in battery metals recycling and refining, today announced that it has entered into a term sheet to acquire Lion Energy, LLC, a U.S.-based provider of commercial, residential, and distributed energy storage systems, consumer power solutions, and proprietary energy managem

    2/11/26 9:00:00 AM ET
    $AQMS
    Metal Fabrications
    Industrials

    American Rebel Holdings Announces Strategic Transition to OTC Markets and Confirms Board Decision Not to Appeal Nasdaq Delisting Determination

    Company remains fully reporting with the SEC; reaffirms growth strategy and longer-term goal to relist stronger on a national exchange Nashville, Tennessee, Feb. 11, 2026 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ:AREB; AREBW), AREBW) ("American Rebel" or the "Company") today announced that its Board of Directors has determined that the Company will not appeal the Nasdaq Staff Delisting Determination received on February 4, 2026, and will instead pursue a structured transition to OTC Markets, where the Company expects to initially seek quotation on OTCID, with the goal of pursuing an upgrade to OTCQB (and potentially higher tiers) as eligibility requirements are met. The C

    2/11/26 7:00:00 AM ET
    $AREB
    Plastic Products
    Industrials

    $ACRX
    $AEZS
    $ALNA
    $APRE
    SEC Filings

    View All

    American Rebel Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AMERICAN REBEL HOLDINGS INC (0001648087) (Filer)

    2/11/26 5:29:54 PM ET
    $AREB
    Plastic Products
    Industrials

    SEC Form DEFA14A filed by Aqua Metals Inc.

    DEFA14A - Aqua Metals, Inc. (0001621832) (Filer)

    2/11/26 5:25:21 PM ET
    $AQMS
    Metal Fabrications
    Industrials

    Aqua Metals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits

    8-K - Aqua Metals, Inc. (0001621832) (Filer)

    2/11/26 5:25:01 PM ET
    $AQMS
    Metal Fabrications
    Industrials

    $ACRX
    $AEZS
    $ALNA
    $APRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President/CEO Gilad Oren bought $25,009 worth of shares (28,100 units at $0.89), increasing direct ownership by 8% to 373,720 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:08:08 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $5,073 worth of shares (5,700 units at $0.89), increasing direct ownership by 21% to 33,433 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:05:34 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ACRX
    $AEZS
    $ALNA
    $APRE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $AEZS
    $ALNA
    $APRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Atlassian with a new price target

    BMO Capital Markets reiterated coverage of Atlassian with a rating of Outperform and set a new price target of $130.00 from $135.00 previously

    2/6/26 6:48:33 AM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Atlassian with a new price target

    BMO Capital Markets reiterated coverage of Atlassian with a rating of Outperform and set a new price target of $135.00 from $195.00 previously

    2/4/26 7:57:19 AM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Deutsche Bank resumed coverage on Prudential Plc

    Deutsche Bank resumed coverage of Prudential Plc with a rating of Buy

    1/7/26 9:14:06 AM ET
    $PUK
    Life Insurance
    Finance

    $ACRX
    $AEZS
    $ALNA
    $APRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Yakira Capital Management, Inc. sold $153,761 worth of 7.00% Series A Cumulative Redeemable Preferred Shares (6,380 units at $24.10) (SEC Form 4)

    4 - Seritage Growth Properties (0001628063) (Issuer)

    2/9/26 5:07:57 PM ET
    $SRG
    Real Estate
    Finance

    Director Farquhar Scott sold $726,716 worth of shares (7,665 units at $94.81) (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    2/6/26 5:36:08 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    CEO, Co-Founder Cannon-Brookes Michael sold $726,716 worth of shares (7,665 units at $94.81) (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    2/6/26 5:35:50 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    $ACRX
    $AEZS
    $ALNA
    $APRE
    Leadership Updates

    Live Leadership Updates

    View All

    Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor

    DOYLESTOWN, Pa., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies that exploit cancer-specific vulnerabilities while minimizing damage to healthy cells, today announced the appointment of Eugene (Gene) Kennedy, MD, as Chief Medical Advisor. Dr. Kennedy joins Aprea at an important time, following the Company's recent early clinical proof-of-concept demonstrated in its ongoing Phase 1 dose-escalation study evaluating the WEE1 inhibitor APR-1051 in patients with advanced solid tumors. He is a highly accomplished physician scientist and biopharmaceutical executive wit

    2/4/26 8:30:00 AM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MediaCo Appoints Maire Mason to Lead Local Radio and Television Operations, Driving Major New York Market Shift

    Veteran Executive Joins MediaCo to Oversee NYC, Chicago, and Denver with Additional Expansion Planned MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Maire Mason as Vice President and General Manager of Local MediaCo Markets, marking a significant leadership move in the New York radio and television landscape. In this role, Mason will oversee MediaCo's local radio and television operations across New York City, Chicago, and Denver, with responsibility for marquee brands including HOT 97 (WQHT-FM), WBLS-FM, Luna 107.5 (WBLS-HD2), La Buena (WQHT-HD2), and EstrellaTV's WMBC-TV in the New York tri-state area. MediaCo expects Mason's responsibilities to expand to additi

    1/26/26 8:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    Atlassian Appoints Anil Sabharwal to Board of Directors

    Atlassian Corporation (NASDAQ:TEAM), a leading provider of team collaboration and productivity software, today announced it is appointing Anil Sabharwal to its Board of Directors, effective February 1, 2026. Anil is Vice President of Product at Google, having held various senior leadership roles at the company for 17 years. In addition, in 2025, Anil served as a technical advisor to Atlassian, overseeing its new partnership with the Atlassian Williams Racing Formula One Team. "Anil builds products people can't live without. He's spent his career helping ambitious companies scale responsibly, and he knows how to make products smarter, more helpful, and more human with AI. That's exactly th

    1/15/26 4:05:00 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    $ACRX
    $AEZS
    $ALNA
    $APRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by SCWorx Corp.

    SC 13G - SCWorx Corp. (0001674227) (Subject)

    12/5/24 7:17:43 AM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form SC 13G filed by SCWorx Corp.

    SC 13G - SCWorx Corp. (0001674227) (Subject)

    11/26/24 5:02:01 PM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by American Rebel Holdings Inc.

    SC 13G/A - AMERICAN REBEL HOLDINGS INC (0001648087) (Subject)

    11/14/24 3:48:04 PM ET
    $AREB
    Plastic Products
    Industrials

    $ACRX
    $AEZS
    $ALNA
    $APRE
    Financials

    Live finance-specific insights

    View All

    Upstart Announces Fourth Quarter and Full Year 2025 Results

    Announces Leadership Evolution Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, today announced financial results for the quarter and full year ended December 31, 2025. Upstart will host a conference call and webcast at 1:30 p.m. Pacific Time today. An earnings presentation and link to the webcast are available at ir.upstart.com. "In 2025, we grew originations 86% and revenues 64% while growing headcount just 18% — a ratio any business would die for. And we re-established Upstart as a strongly profitable business," said Dave Girouard, Co-founder and CEO of Upstart. "Our auto and home originations each grew 5X in 2025 — and accelerated e

    2/10/26 4:03:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Atlassian Announces Date for Second Quarter of Fiscal Year 2026 Financial Results

    Atlassian Corporation (NASDAQ:TEAM), a leading provider of team collaboration and productivity software, today announced that it will release financial results for its second quarter of fiscal year 2026 ended December 31, 2025 after market close on Thursday, February 5, 2026. Atlassian will host a conference call to discuss the financial results at 2:00 P.M. Pacific Time. In conjunction with its earnings press release, Atlassian will post a shareholder letter to the Investor Relations section of its website at https://investors.atlassian.com. Webcast Details When: Thursday, February 5, 2026 at 2:00 P.M. Pacific Time (5:00 P.M. Eastern Time). Webcast: A live webcast of the call can b

    1/13/26 4:05:00 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Upstart to Announce Fourth Quarter and Full Year 2025 Results on February 10, 2026

    Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, will hold a conference call to discuss its fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, at 1:30 p.m. PT / 4:30 p.m. ET. The company's earnings press release and investor presentation will be available on its investor relations website at ir.upstart.com after the market closes that day. Live webcast. The live webcast and a replay will be available on Upstart's investor relations website. Conference Call Dial-In. To access the live conference call in the United States and Canada: 800-330-6710, conference code 8139985. To access the live conference call

    1/12/26 4:05:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance